US approves Moderna vaccine for COVID-19
The US Food and Drug Administration authorized an emergency rollout of the COVID-19 vaccine developed by Moderna and the National Institutes of Health.
Associated Press
Representative image: Reuters
The US added a second COVID-19 vaccine to its arsenal on December 18, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
Much-needed doses are set to arrive on December 21 after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health.
The move marks the world’s first authorization for Moderna’s shots. The vaccine is very similar to one from Pfizer Inc. and Germany’s BioNTech that’s now being dispensed to millions of health care workers and nursing home residents as the biggest vaccination drive in U.S. history starts to ramp up.